🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, and dose...
Status
Completed
Location
Multiple Locations
Start Date
2014-02-18
Trial ID
NCT01998971
This is a phase 2, single-arm, open label, multicenter study evaluating the...
Status
Completed
Location
Georgetown University Medical Center
Start Date
2008-02
Trial ID
NCT00636792
Treatments Being Tested
RATIONALE: Bortezomib may interfere with the growth of tumor cells by block...
Status
Completed
Location
Cancer Care Ontario-Hamilton Regional Cancer Centre
Start Date
2003-01
Trial ID
NCT00052507
Treatments Being Tested
The purpose of this study is to evaluate if the addition of Bortezomib (Vel...
Status
Completed
Location
Istituto Clinico Humanitas
Start Date
2008-02
Trial ID
NCT00636311
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride li...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2001-05
Trial ID
NCT00237627
The purpose of this study is to determine whether doxorubicin hydrochloride...
Status
Unknown
Location
the First Affiliated Hospital of Soochow University
Start Date
2015-10
Trial ID
NCT02577783
Pirmary endpoint: to examine the feasibility of using an mHealth app for re...
Status
Completed
Location
Odense University Hospital
Start Date
2021-05-01
Trial ID
NCT05724966
Treatments Being Tested
This is a Phase II study of daratumumab based therapies for older adults wi...
Status
Completed
Location
H. Lee Moffitt Cancer & Research Institute
Start Date
2019-11-22
Trial ID
NCT04151667
Treatments Being Tested
This phase II trial studies the side effects and best dose of bortezomib wh...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2007-02-13
Trial ID
NCT00439556
This phase II trial studies how well combination chemotherapy with or witho...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-08-24
Trial ID
NCT00967369
Treatments Being Tested